Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Human NLRP3/NALP3 (aa 4-223) Antibody, R&D Systems™

Sheep Polyclonal Antibody
Supplier: R&D Systems AF6789SP
This item is not returnable.
View return policy
Description
NLRP3/NALP3 Polyclonal specifically detects NLRP3/NALP3 in Human samples. It is validated for Western Blot, Simple Western, Immunocytochemistry.Specifications
NLRP3/NALP3 | |
Polyclonal | |
Unconjugated | |
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative | |
AGTAVPRL, AII, AII/AVP, Angiotensin/vasopressin receptor AII/AVP-like, AVP, C1orf7, Caterpiller protein 1.1, CIAS1, CLR1.1, Cold autoinflammatory syndrome 1, Cold autoinflammatory syndrome 1 protein, Cryopyrin, Familial cold autoinflammatory syndrome, FCAS, FCU, Leucine-rich repeat-, and PYD-containing protein 3, Muckle-Wells syndrome, MWS, NACHT, NACHT, LRR and PYD containing protein 3, NACHT, LRR and PYD domains-containing protein 3, NALP3, NLR family, pyrin domain containing 3, NLRP3, Nucleotide-Binding Oligomerization Domain, Leucine Rich Repeat And Pyrin Domain Containing 3, PYPAF1, PYRIN-containing APAF1-like protein 1 | |
Sheep | |
Affinity Purified | |
RUO | |
114548 | |
Sterile PBS to a final concentration of 0.2 mg/mL. | |
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution. |
Western Blot, Immunocytochemistry | |
LYOPH | |
Western Blot 0.5 μg/mL, Simple Western 50 μg/mL, Immunocytochemistry 5-15 μg/mL | |
Q96P20 | |
NLRP3 | |
E. coli-derived recombinant human NLRP3/NALP3 Ala4-Val223 Accession # Q96P20 | |
25 μg | |
Primary | |
Detects human NLRP3/NALP3 in direct ELISAs and Western blots. In direct ELISAs, less than 1% cross-reactivity with recombinant human (rh) NALP1 and rhNALP2 is observed. | |
Human | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction